Is CORERX, INC. FDA approved?

CORERX, INC. holds 1 FDA-registered establishment in the United States. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.

Where are CORERX, INC.'s drugs manufactured?

The FDA register lists Clearwater, FL. Registered operations: analytical testing, labelling, finished drug manufacture, packaging.

What drugs does CORERX, INC. make?

12 products are listed under CORERX, INC. in the openFDA NDC Directory, most often as powder; tablet; capsule. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

CORERX, INC.

Data as of 24 Sept 2026 · How to read this entry

Request a quote Claim this profile

Registered sites: 1
Active NDC listings: 12
Live patents: 0
Countries: 1
Base: United States

Authorisation

Registered operations

Analytical testing1Labelling1Finished drug manufacture1Packaging1

Sites

Registered establishments

Establishment	Address	Registered for	FEI / DUNS
CORERX, INC.	14205 Myerlake Circle, Clearwater, Florida (FL) 33760, United States (USA)	Analytical testing, Labelling, Finished drug manufacture, Packaging	3007209985780516717

Catalogue

Drug listings by form and route

12 active NDC listings: 12 drug for further processing. By marketing category: DRUG FOR FURTHER PROCESSING 12.

Dosage form	NDCs
powder	7
tablet	3
capsule	1
solution	1

Route	NDCs

Labeller name on the listing	NDCs
corerx, inc.	12

Catalogue

Marketed products

Brand	Generic name	Form / route	NDC
-	AMINOCAPROIC ACID	solution	51767-151DRUG FOR FURTHER PROCESSING
-	AMPHETAMINE SULFATE	tablet	51767-227DRUG FOR FURTHER PROCESSING
-	AMPHETAMINE SULFATE	tablet	51767-228DRUG FOR FURTHER PROCESSING
-	EFLORNITHINE HYDROCHLORIDE	tablet	51767-150DRUG FOR FURTHER PROCESSING
-	FINASTERIDE AND TADALAFIL	capsule	51767-025DRUG FOR FURTHER PROCESSING
-	Peanut	powder	51767-111DRUG FOR FURTHER PROCESSING
-	Peanut	powder	51767-112DRUG FOR FURTHER PROCESSING
-	Peanut	powder	51767-121DRUG FOR FURTHER PROCESSING
-	Peanut	powder	51767-122DRUG FOR FURTHER PROCESSING
-	Peanut	powder	51767-123DRUG FOR FURTHER PROCESSING
-	Peanut	powder	51767-124DRUG FOR FURTHER PROCESSING
-	Peanut	powder	51767-125DRUG FOR FURTHER PROCESSING

Neighbours

Registered in the same town

QOL MEDICALCLEARWATER, FL
SURPRISE ENTERPRISE LLCClearwater, FL

Compare

Comparable companies in United States

Hahnemann Laboratories, Inc. dba Alpine Pharmaceuticals1 site · 4,853 NDC
NuCare Pharmaceuticals,Inc.1 site · 1,393 NDC
Greer Laboratories, Inc.1 site · 1,328 NDC
ASCLEMED USA INC. DBA ENOVACHEM1 site · 789 NDC
Golden State Medical Supply Inc.1 site · 670 NDC
Rising Pharma Holdings, Inc.1 site · 532 NDC
HF Acquisition Co LLC1 site · 363 NDC
ANI Pharmaceuticals, Inc.1 site · 299 NDC
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.1 site · 273 NDC
Newton Laboratories, Inc.1 site · 271 NDC

Enquiry

Common questions

Is CORERX, INC. FDA approved?: CORERX, INC. holds 1 FDA-registered establishment in the United States. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are CORERX, INC.'s drugs manufactured?: The FDA register lists Clearwater, FL. Registered operations: analytical testing, labelling, finished drug manufacture, packaging.
What drugs does CORERX, INC. make?: 12 products are listed under CORERX, INC. in the openFDA NDC Directory, most often as powder; tablet; capsule. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.